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INTRODUCTION
Nonmelanoma skin cancer is the most
common malignancy in human beings, and
its incidence continues to increase.1,2 Skin can-
cers, like other human tumors, arise from a
single transformed cell that presumably gained
growth advantage through damage to the
genes that control cell proliferation.3 The
neoplastic clone, in which proliferative con-
trols are disrupted, may also have a higher
propensity to develop further genetic abnor-
malities.4 As the genome becomes unstable,
the cell is more prone to develop large-scale
chromosome aberrations, amplifications, de-
letions and translocations. The consequent
accumulation of genetic abnormalities is as-
sociated with increasing genetic heterogene-
ity in the tumor clone.5-7
Genome instability has been characterized
in the majority of human tumors as chromo-
somal instability (aneuploidy, deletions or
amplifications).7 Tumor groups exhibit muta-
tions on a smaller scale, such as nucleotide in-
stability,8 minisatellite instability9 or
microsatellite instability.10 Microsatellite insta-
bility is manifested by small deletions or ex-
pansion in the copy number of tandem repeat
sequences in tumor DNA, as compared with
matching normal DNA.10 First discovered in
hereditary nonpolyposis colorectal cancer syn-
drome, which is one of the most common syn-
dromes associated with cancer predisposition
in man, microsatellite instability has been im-
plicated in about 15% of sporadic colorectal
cancers, as well as in cancers at several other
sites such as the bladder and stomach.10-12
Numerous observations have shown that
alterations in microsatellite DNA, although
random, tend to be associated with the muta-
tion of genes that control cell growth and
apoptosis, and such modifications at micro-
satellite loci seem to play an important role in
the development of human cancers.12
Because karyotype abnormalities have
frequently been reported in melanocytic le-
sions and a high frequency of heterozygosity
loss has been demonstrated in chromosome
9, it has been proposed that this chromo-
some contains one or more tumor suppres-
sor genes that may also be involved in squa-
mous cell and basal cell carcinomas.13-17
p16INK4a is a tumor suppressor protein
encoded by the CDKN2A gene in the 9p21
region, a gene that can generate different
transcripts. It functions as an inhibitor of the
D-type cyclin-dependent kinases 4 and 6
(CDK4 and CDK6) that are involved in cell
cycle regulation. Inactivation of p16 is a fre-
quent event in epidermoid squamous cell
cancers in general and has been related to
familial melanoma, but its role in basal cell
skin carcinomas is still unclear.
The objective of this study was to investi-
gate the role of allelic imbalance in human
chromosome 9p21-p22, in basal cell carcino-
mas, in comparison with a series of sporadic
benign and malignant skin lesions.
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METHODS
The study was approved by the Ethics
Committee of the University Hospital of the
Faculdade de Medicina da Universidade
Estadual de Campinas (Unicamp), and in-
formed written consent was obtained from a
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CONTEXT: Loss of heterozygosity in the 9p21-p22 re-
gion, has been frequently described in a wide
range of human malignancies, including familial
melanomas. Also, losses and gains in other re-
gions of chromosome 9 have frequently been ob-
served and may indicate additional mechanisms
for basal cell tumorigenesis.
OBJECTIVE: To investigate allelic imbalance in the
9p21-p22 region, among basal cell carcinomas.
TYPE OF STUDY: Microsatellite analysis.
SETTING: Two dermatology services of public univer-
sities in São Paulo and the Laboratory of Cancer
Molecular Genetics of Universidade Estadual de
Campinas (Unicamp).
PARTICIPANTS: 13 patients with benign skin lesions
consecutively referred to the outpatient dermatol-
ogy clinics of Unicamp and Universidade Estadual
de São Paulo (Unesp) and 58 with malignant skin
tumours.
MEAN MEASUREMENTS: We examined 13 benign
cases including four of solar keratosis, three
keratoachanthomas, three melanocytic nevi, two of
Bowen’s disease and one of neurofibroma, and 58
malignant skin tumors: 14 of squamous cell, 40 ba-
sal cell carcinomas and four melanomas. Participat-
ing patients had the main tumor and a normal por-
tion of non-adjacent skin surgically removed. DNA
was extracted from the tumor and matching normal
tissue. We used four sets of primers to amplify poly-
morphic microsatellite repeats on chromosome 9,
two of them targeting the 9p21-p22 region.
RESULTS: We identified eight cases (20%) of allelic
imbalance among basal cell carcinomas, two
cases of loss of heterozygosity and six cases of
microsatellite instability in the 9p21-p22 region.
Additional markers were also involved in three of
these tumors. No events were detected among the
benign or the other malignant cases.
CONCLUSION: This phenotype dependency suggests
that there is a major distinction between the two
most important forms of nonmelanoma skin can-
cers in their tendency to present microsatellite in-
stability in chromosome 9. Since the CDKN2a/
p16INK4a, p19ARF and p15INK4b tumor suppres-
sor genes do not appear to be responsible for the
observed abnormalities, other genes at 9p21-p22
may be involved in the pathogenesis and progres-
sion pathway of basal cell carcinomas.
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letotal of 71 patients. Thirteen presented be-nign lesions and 58 had malignant skin
tumors. The benign cases included four solar
keratosis, three keratoachanthomas, three
melanocytic nevi, two cases of Bowen’s dis-
ease and one neurofibroma. The malignant
skin tumors included 14 squamous cell (8
males and 6 females, aged 52 ± 12 years old),
40 basal cell carcinomas (20 males and 20 fe-
males, aged 54 ± 16 years old) and four
melanomas (2 males and 2 females, aged 51 ±
14 years old). All patients were carefully ex-
amined and previous medical conditions were
particularly considered, especially organ trans-
plantation, immunosuppressive therapy, other
malignancies and HIV infection.
DNA from a central part of the tumor and
DNA from normal adjacent skin tissue samples
were isolated immediately after surgical resec-
tion, according to standard methods, using pro-
teinase K digestion and phenol-chloroform ex-
traction. The DNA concentration was deter-
mined by means of 260/280 spectrophotom-
etry. Two sets of primers obtained from Research
Genetics (Huntsville, Alabama) were used to
amplify the D9S200 and D9S1748 loci at 9p12-
p21. Another pair of primers targeted the 9q31-
34 region (D9S120) and, finally, one pair of
primers targeted the 9p22-23 region (D9S156).
Primer sequences were extracted from the Ge-
nome Database via the internet (http://
www.gdb.org). The polymerase chain reaction
(PCR) was performed using 20-µl volumes of a
mixture containing 30-50 ng of DNA, 50 nm
of each primer, 10 mM tris-HCl (pH 8.0), 50
mM MgCl
2
, 100 uM of each dinucleotide tri-
phosphate and 0.5 U Taq of DNA polymerase.
The MgCl
2
 concentrations ranged from 1 to
1.75 mM and the annealing temperatures var-
ied from 56 to 62° C. Amplifications were car-
ried out for 35 cycles of 94º C for 45 seconds,
56-62º C for 45 seconds and 72º C for 1 min,
with an initial denaturation step of 94º C for 2
min and a final extension step of 72º C for 7
min using a Perkin-Elmer 9600 GeneAMp PCR
system. The PCR products were mixed with
loading buffer (95% formamide, 20 mM EDTA,
0.05% bromophenol blue, 0.05% xylene cyanol)
and 6 µl of this mixture was combined with 6 µl
of heat-denatured formamide. This was run over-
night at 65 V, on 8% polyacrylamide, 7-M urea
gel stained with silver nitrate. Informative pa-
tients were identified and the allelic loss was
scored using the GeneScan software (Kodak).
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RESULTS
All 71 cases were informative for at least one
of the primers used to examine the 9p21-p22
chromosome region. Cases were scored as show-
ing allelic imbalance if the ratio between the two
alleles in the tumor was 50% less than what was
detected for the normal sample. A significant
reduction of more than 65% of the signal inten-
sity of one of the two tumor alleles was recorded
as loss of heterozygosity (although this does not
formally exclude allelic imbalance secondary to
amplification of one allele). Microsatellite insta-
bility was defined by the presence of bands that
were absent from the normal sample. Ho-
mozygous cases were considered not informa-
tive for loss of heterozygosity.
Two basal cell carcinomas presented het-
erozygosity loss (Figures 1a and 1d) and six
basal cell carcinomas showed an extra band
with one of the microsatellite markers for the
9p21 region (Figure 1c). Three of these six
basal cell carcinoma patients also showed al-
lelic imbalance in the 9p23-p22 region and
two of them additionally presented an extra
band at the 9q31-q34 locus, thus indicating
replication errors (Figure 1b ). All of these
eight patients were white and presented mul-
tiple skin lesions, particularly at sun-exposed
sites. The tumors examined were excised from
the head/neck region of five patients and from
the chest and back, respectively, of three other
patients. We were not able to identify any clini-
cal pattern that could differentiate these cases
from the remaining basal cell patients.
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DISCUSSION
Tumors arise from a series of selection
pressures that favor growth and survival.3 A
large proportion of skin cancers, the most
common malignancies in the Western world,
are of nonmelanoma type. Basal cell carcino-
mas account for more than 75% of cases and
squamous cell carcinomas for a further
20%.1,2,18-20 Epidemiological studies suggest
that sunlight (particularly ultraviolet-B radia-
tion, UVB) is a strong risk factor for the ap-
pearance of basal cell carcinoma, although
other factors are also involved.19,20 Squamous
cell carcinomas of the skin also are associated
with exposure to UV light and both basal cell
Sao Paulo Med J 2004; 122(1):18-21.
Figure 1. Examples of allelic imbalance. Panel a shows allelic imbalance of the tumor (allelic ratio 75% less than the corre-
sponding normal alleles) in the first pair of samples and a loss of heterozigosity in the third pair of basal cell carcinoma samples
tested with the D9S1748 marker. Panel b demonstrates that the latter tumor exhibits an extra band on 9q31-34, using the
D9S120 marker. Panels c and d show basal cell carcinoma samples presenting microsatellite instability and loss of heterozigosity
at 9q12-21, using the D9S200 and D9S1748 markers, respectively.
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and squamous cell carcinomas are derived
from the same cell type, the keratinocyte cell.
However, in contrast with squamous cell car-
cinoma, basal cell carcinomas are slow-grow-
ing, locally invasive tumors that rarely pro-
duce metastasis.19,20
Microsatellite instability has been identi-
fied in a wide variety of human tumors, both
familial and sporadic. It is associated with early
or late stages of tumor progression, and a
higher frequency of microsatellite instability
has been noted in certain tumor subtypes.10,12
Using 71 paired samples of normal and tumor
DNA, amplified by PCR for the analysis of
polymorphic dinucleotide repeats on chromo-
some 9, we obtained a 20% rate of allelic im-
balance in basal cell carcinomas. In contrast,
there were no such events in lesions due to
squamous cell carcinoma or malignant
melanomas, or in benign lesions. In agreement
with our data, a recent study on basal cell car-
cinomas using comparative genomic hybridi-
zation has demonstrated recurrent chromo-
somal gains at 9p in 20% of the cases, which
was coincidentally the same rate of allelic im-
balance we obtained.21
We found evidence of frequent chromo-
somal instability in the 9p21-p22 region that
harbors the CDKN2a/p16INK4a, p19ARF
and p15INK4b tumor suppressor genes. Loss
of p16 function is associated with increased
susceptibility to a variety of malignancies, and
germline mutations of p16INK4a have been
found in up to 20-30% of melanoma-prone
families.22-24 The INK4a-ARF locus also plays
an important role in sporadic nonmelanoma
skin cancers. p16INK4a UV-induced muta-
tions (CC:GG > TT:AA tandem transition or
C:G > T:A transition at dipyrimidine sites)
have been described in up to 12% of sporadic
skin carcinomas and seem to occur independ-
ently from p53 mutations.24
Some early data reported low frequencies
of 9p loss and p16 mutations in basal cell car-
cinomas, in contrast to findings from squamous
cell carcinomas.14,25 More recently, Saridaki et
al., although reporting a lack of mutations of
p16INK4a/p19ARF among Greek patients
with basal cell carcinoma of the skin, found
similarly high frequencies of heterozygosity loss
at the 9p21-p22 region in basal cell and squa-
mous cell carcinomas.26,27 These data contrast
with ours, and could reflect a particular genetic
pattern related to our population.
With regard to squamous cell carcinomas,
Kushida et al., studying Japanese patients,
found no microsatellite instability in 37 ac-
tinic keratosis and 14 sporadic squamous cell
cases studied using six microsatellite markers.
Loss of heterozygosity was found in 7 actinic
keratosis cases, but in only one case of squa-
mous cell carcinoma, thus leading these au-
thors to conclude that actinic keratosis was
not likely to proceed to squamous cell carci-
nomas in such patients.28 On the other hand,
there has been recent evidence that the loss of
p16(INK4a) is implicated in the progression
of actinic keratosis lesions to squamous cell
carcinomas, at least among Caucasians.29
Microsatellite instability has been reported in
keratoacanthoma patients, but at a low fre-
quency that suggests that these genetic events
are uncommon in sporadic lesions.30,31
Three of our basal cell carcinoma cases
presented instability in two or more markers
of chromosome 9, thus suggesting the exist-
ence of a subgroup of patients that may be
more prone to presenting allelic imbalance or
replication errors. Unfortunately, we were
unable to identify any particular pattern that
could differentiate such patients from the re-
maining basal cell cases.
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CONCLUSIONS
The fact that only basal cell carcinomas
presented allelic imbalance suggests that there
is a major distinction between the two most
important forms of nonmelanoma skin can-
cers in their tendencies to present microsatellite
instability in chromosome 9. This is likely to
result from a fundamental difference in the
mechanisms controlling chromosomal stabil-
ity in these two forms of cancer and demon-
strates that basal cell carcinomas may be more
genetically unstable than previously thought.
Since the CDKN2a/p16INK4a, p19ARF
and p15INK4b tumor suppressor genes do not
appear to be responsible for the abnormalities
observed,26 other genes at 9p21-p22 may be
involved in the pathogenesis and progression
pathway of basal cell carcinomas.
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Estudos de equilíbrio alélico do cromossomo 9
sugerem grandes diferenças na estabilidade
cromossômica dos tumores dermatológicos
de linhagem não-melanocítica
CONTEXTO: Vários estudos de perda de
heterozigozidade na região 9p21-p22, que abri-
ga os genes supressores tumorais CDKN2a/
p16INK4a, p19ARF e p15INK4b, têm sido
realizados em uma ampla série de tumores hu-
manos, incluindo os melanomas familiares. Per-
das e ganhos em outras regiões do cromossomo
9 também têm sido observados com freqüência
e podem indicar mecanismos adicionais no pro-
cesso de tumorigênese dos carcinomas
basocelulares da pele.
OBJETIVO: Investigar o equilíbrio alélico exis-
tente na região 9p21-p22 em carcinomas ba-
socelulares.
TIPO DE ESTUDO: Análise molecular de
marcadores de microssatélites em tumores e
controles.
LOCAL: Dois serviços de dermatologia de aten-
dimento terciário em universidades públicas
de São Paulo e o Laboratório de Genética
Molecular do Câncer da Universidade Esta-
dual de Campinas (Unicamp), Brasil.
PARTICIPANTES: Examinamos 13 casos benig-
nos, incluindo 4 queratoses solares, 3
queratoacantomas, 3 nevos melanocíticos, 2
doenças de Bowen e 1 neurofibroma cutâneo,
além de 58 tumores malignos da pele: 14 de
células escamosas, 40 carcinomas baso-
celulares e 4 melanomas; em pacientes con-
secutivamente encaminhados à clínica de
Dermatologia da Unicamp e que concorda-
ram em participar do estudo.
VARIÁVEIS ESTUDADAS: O tumor principal
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Publishing information
e uma porção normal de pele não-adjacente
foram removidos cirurgicamente de pacien-
tes que consecutivamente procuraram os
ambulatórios de dermatologia da Universi-
dade Estadual de Campinas (Unicamp) e da
Universidade Estadual de São Paulo (Unesp),
São Paulo, por causa de lesões cutâneas. Ex-
traímos DNA tanto de tecido tumoral como
do correspondente tecido normal de cada
paciente. Para amplificar regiões de repetição
polimórfica de microssatélites do cromos-
somo 9, foram utilizados quatro pares de
primers, sendo dois deles destinados à região
9p21-p22.
RESULTADOS: Identificamos oito casos (20%)
de desequilíbrio alélico entre os carcinomas
basocelulares, sendo dois casos de perda de
heterozigozidade e seis casos de instabilidade
de microssatélite na região 9p21-p22. Ou-
tros marcadores também mostravam anorma-
lidades em três destes tumores, enquanto ne-
nhuma alteração foi detectada entre os casos
benignos e nos outros tumores malignos.
CONCLUSÃO: Esta dependência fenotípica su-
gere que existem diferenças importantes no
comportamento das formas mais comuns de
tumores cutâneos não-melanocíticos em re-
lação à sua tendência para instabilidade de
microssatélite no cromossomo 9. Consideran-
do-se que os genes CDKN2a/p16INK4a,
p19ARF e p15INK4b não parecem respon-
sáveis pelas anormalidades observadas, outros
genes em 9p21-p22 podem estar envolvidos
na etiopatogenia e na progressão dos carci-
nomas basocelulares.
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